Department of Medical Oncology;
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital;
Chinese Academy of Medical Sciences and Peking Union Medical College;
Beijing 100021;
China;
Department of Pulmonary Medicine (Inpatient Area 1);
Affiliated Tumor Hospital of Xinjiang Medical University;
Urumqi 830000;
China;
Department of Respiratory Medicine;
Peking Union Medical College Hospital;
Beijing 100730;
China;
Department of Oncology;
the Second Affiliated Hospital of Harbin Medical University;
Harbin 150001;
China;
Department of Tumor Chemotherapy and Radiation Sickness;
Peking University Third Hospital;
Beijing 100191;
China;
Crizotinib; anaplastic; lymphoma; kinase; non-small-cell; lung; cancer; real-world; study;